Huafeng Xu - Route1 Chief Officer
| ROI Stock | CAD 0.02 0.00 0.00% |
Insider
Huafeng Xu is Chief Officer of Route1 Inc
| Address | 7300 North Via Paseo Del Sur, Scottsdale, AZ, United States, 85258 |
| Phone | 866 286 7330 |
| Web | https://www.route1.com |
Route1 Management Efficiency
The company has return on total asset (ROA) of (0.0299) % which means that it has lost $0.0299 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6905) %, meaning that it generated substantial loss on money invested by shareholders. Route1's management efficiency ratios could be used to measure how well Route1 manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.3 in 2024. Return On Capital Employed is likely to climb to -0.42 in 2024. At this time, Route1's Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to climb to about 204.8 K in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 17.3 K in 2024.Similar Executives
| Showing other executives | INSIDER Age | ||
| Benoit Pinsonneault | Rubicon Organics | N/A | |
| John Kramer | High Liner Foods | N/A | |
| Craig Murray | High Liner Foods | N/A | |
| Melanie Ramsey | Rubicon Organics | N/A | |
| Christopher Woodall | Perseus Mining | N/A | |
| Eva Fong | WELL Health Technologies | N/A | |
| J MacQuarrie | High Liner Foods | N/A | |
| BSc BSc | WELL Health Technologies | 49 | |
| Brian Wynn | High Liner Foods | N/A | |
| Arjun Kumar | WELL Health Technologies | N/A | |
| FCA FCA | High Liner Foods | N/A | |
| FCIS FGIA | Perseus Mining | N/A | |
| Jesse MA | Rubicon Organics | 47 | |
| Johanne McNallyMyers | High Liner Foods | N/A | |
| Chris Mulder | High Liner Foods | N/A | |
| LucPierre MartinPrivat | Guru Organic Energy | N/A | |
| Peter Dierx | Rubicon Organics | N/A | |
| Jillian Hennigar | High Liner Foods | N/A | |
| Amir Javidan | WELL Health Technologies | N/A | |
| Alexis Giguere | Guru Organic Energy | N/A | |
| Michael Frankel | WELL Health Technologies | N/A | |
Management Performance
| Return On Equity | -1.69 | ||||
| Return On Asset | -0.0299 |
Route1 Inc Leadership Team
Elected by the shareholders, the Route1's board of directors comprises two types of representatives: Route1 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Route1. The board's role is to monitor Route1's management team and ensure that shareholders' interests are well served. Route1's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Route1's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Matthew Gline, CEO Director | ||
| Marianne Romeo, Head Management | ||
| Tony Busseri, Chief Executvie Officer and Director | ||
| Huafeng Xu, Chief Officer | ||
| Yamian Quintero, Executive Vice President, Chief Technology Officer | ||
| Barry West, Director | ||
| Peter Chodos, Chief Financial Officer, Executive Vice President, Director | ||
| Josh Chen, G Counsel | ||
| Vivek Ramaswamy, Founder Chairman | ||
| Michael Harris, Independent Chairman of the Board | ||
| Micheal Doolan, Independent Director | ||
| David Fraser, Independent Director | ||
| Brian Levett, Co Sec | ||
| Alex Shpurov, Senior CTO | ||
| Jerry Iwanski, Executive COO | ||
| PharmD MD, Pres COO | ||
| Louis Jong, Director | ||
| Kelly Graff, Head People | ||
| Richard Pulik, Chief Officer | ||
| John Marino, Director | ||
| Rakhi Kumar, Chief Officer | ||
| Edward Reeder, Director | ||
| Mayukh MD, Pres Officer |
Route1 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Route1 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Route1 Stock Analysis
When running Route1's price analysis, check to measure Route1's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Route1 is operating at the current time. Most of Route1's value examination focuses on studying past and present price action to predict the probability of Route1's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Route1's price. Additionally, you may evaluate how the addition of Route1 to your portfolios can decrease your overall portfolio volatility.